Anpario plc (LON:ANP - Get Free Report) shares hit a new 52-week high on Tuesday . The company traded as high as GBX 474 ($5.99) and last traded at GBX 474 ($5.99), with a volume of 110170 shares. The stock had previously closed at GBX 452.50 ($5.72).
Analyst Ratings Changes
Separately, Canaccord Genuity Group lifted their price target on Anpario from GBX 380 ($4.80) to GBX 500 ($6.32) and gave the stock a "buy" rating in a research report on Tuesday, January 14th.
View Our Latest Analysis on Anpario
Anpario Price Performance
The firm has a fifty day moving average of GBX 417.98 and a 200 day moving average of GBX 348.73. The company has a current ratio of 6.15, a quick ratio of 5.16 and a debt-to-equity ratio of 0.10. The company has a market capitalization of £78.99 million, a P/E ratio of 25.57 and a beta of 0.58.
Insider Transactions at Anpario
In related news, insider Karen Prior sold 14,000 shares of the business's stock in a transaction that occurred on Friday, December 13th. The shares were sold at an average price of GBX 380 ($4.80), for a total transaction of £53,200 ($67,214.15). Company insiders own 30.51% of the company's stock.
About Anpario
(
Get Free Report)
Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.
Further Reading
Before you consider Anpario, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anpario wasn't on the list.
While Anpario currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
